LOV domains act as biomolecular sensors for light, oxygen or the environment's redox potential. Conformational changes upon the formation of ac ovalent cysteinyl flavin adduct are propagated throughh ydrogen-bonding networks in the core of designed hybrid phototropin LOV2 domains that incorporate the Bcl homology region 3( BH3) of the key pro-apoptotic protein BH3-interacting-domain death agonist (BID). The resulting change in conformation of af lanking amphiphilic a-helix createsalight-dependent optogenetic tool for the modulation of interactions with the anti-apoptotic B-cell leukaemia-2 (Bcl-2) family member Bcl-x L .
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Light-oxygen-voltage (LOV) domains are molecular switches that act as internal sensors of oxygen, redox potentiala nd light in cells. [1] [2] [3] Some LOV domains function as reversible photoswitches [4] and underpin ar ange of blue-lightr esponses in plants, fungi and bacteria including phototropism [5, 6] and regulation of the circadian rhythm. [7] LOV photosensors share ac ommon mechanism by which an oncovalently bound flavin cofactor absorbs blue light (450-475 nm) to enter an excited electronic state;t his leads to the formation of ac ovalent adduct between flavin mononucleotide (FMN) and the sulfur atom of ac ysteiner esidue, [8] and significant conformational changes occur. [9] The FMN adduct spontaneously revertst oi ts noncovalently bondedd ark state with rates that reflect the functiono ft he individual LOV domain. Phototropin was one of the first blue-light receptorsd iscoveredi np lants, and LOV2 from Avena sativa (AsLOV2) has previously been used for photoprotein engineering. In its dark form, the C-terminal Ja helix of AsLOV2 is tightly bound to the b-sheet (Figure1), but upon light-activated adduct formation, the 20 residues of the C-terminal Ja helix are displaced from the b-sheet, therebye xposing the amphiphilic helix ( Figure 2 ). [10] [11] [12] LOV domains have been used to create light-responsive DNA-binding motifs [13] [14] [15] and transcriptional activators, [16, 17] as well as to control the activityofenzymes [18, 19] and the subcellular location [20] and degradation rates [21] of proteins by domain fusion or insertion. We have previously modified peptides equences from proapoptotic proteins with azobenzene crosslinkers to create biomolecular nanoswitches (BNs), whose conformationsa nd bindingp roperties change in response to light. [22] [23] [24] AL OV-derived protein of equivalent functionality could be genetically encoded and photoactivatedi nv ivo through transient expression or gene integration. AL OV/caspase 7h ybrid hasp reviously been shown to cause cell death; however,o verexpression of Bcl-2, which is common in many types of cancerc ells, diminished its proapoptotic effect. [25] Figure 1. Overall structure of Avenasativa Phototropin1LOV2 domain (PDB ID:2V1A) [12] with the Ja helix in green. Previousw ork has sought to maximise the dynamic range between the light-and dark-state affinities of LOV-peptide fusions, [21, 26] but controlling potentially irreversible apoptotic processes with an expressed protein requires stringent "caging" of the active epitope. Caginge fficiency is affected by the position of the binding epitope in the Ja helix;r esidues incorporated closer to the body of the protein are better caged in the dark state but pay as teric penaltyi nt he light state. Well-characterised protein-protein interaction motifs have been introduced into LOV domains to generate generic photoassociation tools. Incorporating an amino acid sequence that is strongly bound by PSD-95/discslarge/zona occludens 1( PDZ) domains into sites between residues 540 and 545 of the Ja helix of AsLOV2 (Table S1 )l ed to proteins with increased affinitiesf or PDZ in the light-activated state. [27] Introducing the recognition sequence at residue 542 led to the widestd ynamic range between dark-and light-state affinities. Ap rotein database search revealed that peptide sequences similar to AsLOV2 Ja have been crystallised bound to interacting partners. [28] Elements of one such sequence, the SsrA peptide, were incorporated at residues 523, 535, 538 and 542 of the Ja helix of AsLOV2. The abilities of these proteins to bind SspB, the cognate partnero fS srA, were comparedb yf luorescencep olarisation;w hilst the sequence inserted at 538 showed the tightest binding affinity,i nsertion at 542 led to the greatest difference betweenl ight and dark states. Proteins could be marked for light-dependent proteasomal degradation by inserting af our-amino acid degrons, RRRG, at residue 543 of AsLOV2. [21] As equence from ac AMP-dependent kinase inhibitor was inserted into the loop preceding the AsLOV2 Ja,b ut this change led to inhibition of the target enzymee ven in the dark state. [29] In contrast,a ppending the inhibitors equence to the AsLOV2 Ja at residue 452 led to light-dependent inhibition of the target kinase. Ta ken together, these results suggest that only ar ather narrow region of the Ja region of AsLOV2 can be used to generate effective photocaged protein hybrids. This is emphasised by fusions of LOVt o Rac1, aG TPase, in whicht he addition or removal of single amino acids drasticallya lters dark-state caging of the GTPase [30] The key structural recognition element for proapoptotic proteins is the Bcl homology 3region (BH3),w hich binds as an ahelix in as hallow groove found on the surface of Bcl family proteins.B H3 recognition elements are much longer( 21 residues rather than 7-9 residues, Ta bleS1) than the sequences that have previously been incorporated into the Ja helix of AsLOV2, and hydrophobic side chains from four separatet urns contribute strongly to the binding affinity.I na ddition, several intervening residues make highlyc onserved interactions or dictate specificity for anti-apoptotic protein subfamilies. [31] We chose the BH3 domain of BID, ab roadly acting pro-apoptotic protein, asamodel sequence for changes to the Ja of AsLOV2. Key residues of the Ja helix in AsLOV2 determine its dark-state structure ( Figure 1) ;G528A and N538E mutants show increased helix docking in the dark state, whereas AsLOV2-I532Ea nd AsLOV2-A536E create "pseudo-light" mutants by compromising Ja docking. [10, 27] To design an efficient AsLOV2-based optogenetic tool that targets the heterodimers of the Bcl-2 family,t he hydrophobic character of residues I532, A536 and I539 of AsLOV needed to be preserved, and D540, ar esidue that makesa ni mportant electrostatic interaction to the core LOV domain, [10] needed to be retained (Table 1) . Despite these compromises,afluorescently labelled peptide corresponding to the proposed Ja region of the hybrid LOV-BID1 (Table 1) showedo nly at wofold reduction in affinity for
Bcl-x L (K D = 46 AE 2.6 nm)r elative to the parent sequence (Table S4) . Ap lasmidc ontainingD NA encoding AsLOV2 fused to the Cterminus of ad omain used for affinity purification, hisactophilin-C49S, [32] was used to construct hybrids between AsLOV2 and BID BH3. Although wild-type Hisact-AsLOV2 relaxed with ah alf-life of approximately 1min after photoactivation, am utant with ad ifferenth ydrophobic side chain near the active site, Hisact-AsLOV2-V416I, had as ignificantly longerlived (t1 = 2 = 7.7 min) photoactivated state (Table S5) . [33] [34] The hisactophilin prosthetic domain was replaced by aH is-tag, and BH3-like sequences were added at differentp ositions of the Ja helix (Table 1) to generate LOV-BID1-4. Solutionso ft hese hybrids were exposed to 455 nm light generated by an LED, and the recovery of FMN absorbance at 455 nm was followed by UV spectroscopy;t he ellipticity change at 222 nm in the circular dichroism spectrum was measured by detecting the recovery of a-helicity after exposure to blue light. All four proteins were photoresponsive, and the half-lives obtained from CD and UV measurements were broadly similar,v arying between 10.4 (LOV-BID1) and 7.5 min (LOV-BID3;T able 1and S5).
The thermals tabilities of the hybrids, as measured by CD spectroscopy,d ecreased from LOV-BID1 to LOV-BID4 (Table 1) . The degree of structuralc hange shown by CD spectroscopy upon photoactivation is strongly reduced in LOV-BID1 compared to AsLOV2-V416I (Figure 3) . Comparisonofthe mean residue ellipticities of photoactivated states of AsLOV2 (V416I) and LOV-BID1 at 222 nm suggestsadecreased helicity in the dark state, as both the Ja helix in the light state of wild-type AsLOV2 [34] and BID BH3 peptides [22] are unstructured. LOV-BID2 shows little differencei ns tructure between the dark and pho- www.chembiochem.org toactivated states, but single-wavelength monitoring couldb e used to fit ad ecay curve to ac hange at 222 nm. As the value obtained matches the half-life of the otherh ybrids, it appears the Ja helix is either disordered in the dark state or maintains helicity in the photoactivated state rather than cysteinyl-FMN adduct formation becomingd ecoupled from structural changes.M uch larger changes wereo bserved in the CD spectra for light-activated and dark-state LOV-BID1, LOV-BID3 and LOV-BID4 samples. Af luorescence anisotropy assay was used to measure the ability of the hybrids LOV-BID1-4 in their light-activated and dark states to targetf luorescently labelled loop-truncated Bclx L . [22] [23] As expected, no binding was observed for AsLOV2 (V416I) either before or after photoactivation (Figure 4) . LOV-BID hybrids on the other hand, showed high-nanomolar affinities for Bcl-x L in their photoactivated states. Light-state dissociation constants decreased as the length of hybrid Ja helix increased (Table 2) ;this possibly reflects the increased accessibility of the BH3 motif. No binding to Bcl-x L could be measured in the dark-adapted states of LOV-BID1, LOV-BID3 and LOV-BID4, but LOV-BID2 bound to Bcl-x L in the dark with threefold reduced affinity compared to that in its photoactivated state. This suggestst hat the Ja region of LOV-BID2 is poorly caged in the dark state rather than remaining structured in the lightactivated state. Without calculating the dark-state affinities, it is impossible to calculate the dynamic range of LOV-BID1, LOV-BID3 and LOV-BID4. However,t he best dynamic range obtained in previous peptidee xperiments was a2 3-foldd ifference in affinities for an i,i+ +4a zobenzene-conjugated BID peptide. [22] An equivalent dynamic range would equate to ad ark state affinity of approximately 2 mm for LOV-BID4, whichi tg reatly exceeds. Even withoutf urther mutations,s uch as those used elsewhere to modify the strength of Ja-helix docking, the switching magnitude of the LOV-BID proteins reported here is better than in many previousr eports [21, [27] [28] [29] and similart ot he best reported values for LOV-SsrA variants optimized by phage display (36-and 58-fold). [35] The penalty for embedding the BH3 sequence closer to the core of the LOVd omain is relatively low (~2.5-fold) compared to LOV-SsrA proteins (~16-fold). [28] This might reflect the structure of the binding site of the target protein; Bcl-x L presents as hallow groove across one face with space at either end for overhangingp rotein.
Incorporating Bid BH3-derived sequences into the Ja helix of AsLOV2 did not alter the photochemistry of the LOV domain;i tw as generally well tolerated, resulting in proteins that underwent conformational changes in response to irradiation with blue light. The affinity of the embedded BH3 sequences for Bcl-x L was dependent on the conformational state of the LOV-BID fusions, which offer significant potential as optically controlled intracellular modulators of protein-protein interactions. The relative ease of integration of peptide sequences based on amphiphilic helices( in contrast with previous work incorporating more polar sequences) suggestsw ider applicationso fL OV photoswitches to rapidly and reversibly control protein levels and activities with light at the post-translational level. Photo-exposure of peptide epitopes in LOV domain hybridsi ntroduced into transiently or stably transfected cellsw ill generatep otent optogenetic tools that avoid the difficulties of trafficking peptides across the cell membranes and offer acomplementary approachtothe use of azobenzene photoswitches.
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